Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT05231187Completed

T2Resistance - Detection of Resistance Related Genes

Role: lead

NCT03581279Not ApplicableTerminated

Detection of Borrelia Bacteria in Early Stage Lyme Borreliosis Using the T2Lyme Panel

Role: lead

NCT02163889Completed

Serial Therapeutic and Antifungal Monitoring Protocol

Role: lead

NCT02535468Completed

T2Bacteria Panel Pivotal Study

Role: lead

NCT01919762Completed

Detecting Infections Rapidly and Easily for Bacteremia Trial (DIREBT)

Role: lead

NCT01525095Completed

Detecting Infections Rapidly and Easily for Candidemia Trial (DIRECT)

Role: lead

NCT01752166Completed

Detecting Infections Rapidly and Easily for Candidemia Trial - Part 2 (direcT2 Study)

Role: lead

All 7 trials loaded